Interestingly, CYP2E1 activity was increased in steatotic HepaRG cells (Figure 1(d)), similar to what occurs in NAFLD patients [67–69]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.